Benzinga Logo
QQQ
–%
DIA
–%
SPY
–%
TLT
–%
GLD
–%
BTC/USD
–%
Contribute
Sign in
Benzinga Logo
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Range
79.05 - 81.51
Vol / Avg.
713.5K/942.1K
Div / Yield
-
52 Wk
65.3 - 181.83
Mkt Cap
6.4B
Payout Ratio
-
Open
80.66
P/E
-
EPS
-1.02
Shares
79.8M
Outstanding
79.8M
Total Float
68.1M
Benzinga - Oct 15, 2021, 7:48AM
Benzinga - Oct 13, 2021, 7:53AM
Benzinga - Oct 12, 2021, 4:06PM
Benzinga - Oct 12, 2021, 4:05PM
Benzinga - Oct 12, 2021, 4:04PM
Benzinga - Oct 12, 2021, 4:02PM
Benzinga - Oct 12, 2021, 9:26AM
Benzinga - Oct 12, 2021, 8:07AM
Benzinga - Oct 11, 2021, 3:25PM
Benzinga - Oct 11, 2021, 12:18PM
Benzinga - Oct 11, 2021, 9:15AM
Benzinga - Oct 8, 2021, 1:02PM
Benzinga - Oct 4, 2021, 7:11AM
Benzinga - Sep 27, 2021, 8:35AM
Benzinga - Sep 15, 2021, 7:31AM
Benzinga - Aug 24, 2021, 4:39PM
Benzinga - Aug 16, 2021, 9:11AM
load more
Sector: Health Care.Industry: Biotechnology
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-1.290-1.520 -0.2300
REV162.640M164.089M1.449M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Sarepta Therapeutics Questions & Anwsers

Q

How do I buy Sarepta Therapeutics (SRPT) stock?

A

You can purchase shares of Sarepta Therapeutics (NASDAQ: SRPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sarepta Therapeutics's (SRPT) competitors?

Q

What is the target price for Sarepta Therapeutics (SRPT) stock?

A

The latest price target for Sarepta Therapeutics (NASDAQ: SRPT) was reported by Credit Suisse on October 15, 2021. The analyst firm set a price target for 95.00 expecting SRPT to rise to within 12 months (a possible 18.39% upside). 24 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Sarepta Therapeutics (SRPT)?

A

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $80.24 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Sarepta Therapeutics (SRPT) pay a dividend?

A

There are no upcoming dividends for Sarepta Therapeutics.

Q

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

A

Sarepta Therapeutics’s $Q3 earnings are confirmed for after-market on $November 4, 2021.

Q

Is Sarepta Therapeutics (SRPT) going to split?

A

There is no upcoming split for Sarepta Therapeutics.

Q

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

A

Sarepta Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.